We conduct translational research projects across the themes of Diagnostics, Therapeutics and eHealth with Irish and international industry partners.

Our €13m research centre, funded by Science Foundation Ireland and hosted by RCSI, links innovative neurotherapeutics development with genomic and biomarker-based patient stratification, a national eHealth infrastructure and a research-active nationwide clinical network.

Our centre integrates complementary expertise in neuroscience and neurological disease from five leading academic institutions: RCSI, Trinity College Dublin, Dublin City University, NUI Galway and University College Dublin.

We invite partnerships with SMEs and multinational pharmaceutical and biomedical companies in sectors covering:

  • digital and biological biomarkers
  • diagnostic tools
  • therapeutic discovery and development
  • eHealth-enabled patient support platforms
  • clinical trials

Partnering opportunities with us can include research collaborations (fully- or co-funded) and joint applications for research funding (eg. H2020, NIH).

Benefits to industry partners include access to:

  • integrated scientific expertise across neuroscience, clinical neurology, genetics, cell biology, materials chemistry and eHealth
  • state-of-the-art infrastructure across 5 specialist research institutions
  • national neurological clinical network and trial-ready environment
  • genetically-stratified patient population
  • favourable co-funding mechanisms
  • inherent culture of commercialisation and collaboration with industry
  • dedicated grant-writing expertise

We have in-depth experience in industry engagement, technology transfer, IP management and commercialisation. We work closely with the relevant State Agencies and can support partners to obtain appropriate state funding mechanisms.

For more information, please download our FutureNeuro Industry Brochure or to discuss a research partnership with FutureNeuro, please contact Bridget Doyle